26 Jun
2025
16:30 E.S.T.

Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025

Read more

21 May
2025
16:30 E.S.T.

Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025

Read more

12 May
2025
16:30 E.S.T.

Cellectis Reports Financial Results for the First Quarter 2025

Read more

06 May
2025
16:30 E.S.T.

Cellectis to Report First Quarter Financial Results on May 12, 2025

Read more

28 Apr
2025
16:30 E.S.T.

Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting

Read more

13 Mar
2025
18:15 E.S.T.

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Read more

07 Mar
2025
04:36 E.S.T.

Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025

Read more

24 Feb
2025
01:30 E.S.T.

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

Read more

10 Dec
2024
14:50 E.S.T.

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)

Read more

05 Nov
2024
16:30 E.S.T.

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting

Read more